Cargando…

Hyperglycemia Inhibits Complement-Mediated Immunological Control of S. aureus in a Rat Model of Peritonitis

Hyperglycemia from diabetes is associated with increased risk of infection from S. aureus and increased severity of illness. Previous work in our laboratory demonstrated that elevated glucose (>6 mM) dramatically inhibited S. aureus-initiated complement-mediated immune effectors. Here we report i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mauriello, Clifford T., Hair, Pamela S., Rohn, Reuben D., Rister, Nicholas S., Krishna, Neel K., Cunnion, Kenji M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293792/ https://www.ncbi.nlm.nih.gov/pubmed/25610878 http://dx.doi.org/10.1155/2014/762051

Ejemplares similares

Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus
por: Hair, Pamela S, et al.
Publicado: (2012)

Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin
por: Hair, Pamela S., et al.
Publicado: (2017)

Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1
por: Hair, Pamela S., et al.
Publicado: (2018)

Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway
por: Shah, Tushar A, et al.
Publicado: (2014)

Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model
por: Kumar, Parvathi, et al.
Publicado: (2021)

Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants
por: Hair, Pamela S., et al.
Publicado: (2019)

Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)
por: Hair, Pamela S., et al.
Publicado: (2017)

Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats
por: Sharp, Julia A., et al.
Publicado: (2015)

Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT)
por: Gregory Rivera, Magdielis, et al.
Publicado: (2018)

Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease
por: Sass, Laura A., et al.
Publicado: (2015)

Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity
por: Hair, Pamela S., et al.
Publicado: (2017)

Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report
por: Hair, Pamela S., et al.
Publicado: (2021)

Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes
por: Enos, Adrianne, et al.
Publicado: (2021)

Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential
por: Sharp, Julia A., et al.
Publicado: (2014)

Staphylococcus aureus Surface Protein SdrE Binds Complement Regulator Factor H as an Immune Evasion Tactic
por: Sharp, Julia A., et al.
Publicado: (2012)

Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice
por: Bhutta, Maimoona S., et al.
Publicado: (2021)

Complement Activation and STAT4 Expression Are Associated with Early Inflammation in Diabetic Wounds
por: Cunnion, Kenji M., et al.
Publicado: (2017)

Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal with Peptide Inhibitor of Complement C1 (PIC1)
por: Cunnion, Kenji M., et al.
Publicado: (2019)

Role of Molecular Diagnostics in the Management of Infectious Disease Emergencies
por: Krishna, Neel K., et al.
Publicado: (2012)

997. RLS-0071 Improves Survival in a Rat Model of Intestinal Necrosis
por: Cunnion, Kenji, et al.
Publicado: (2021)

An 11-Year-Old Male with Refractory Osteomyelitis
por: Mauriello, Clifford T., et al.
Publicado: (2012)

Peptide inhibition of acute lung injury in a novel two-hit rat model
por: Sampson, Alana C., et al.
Publicado: (2021)

The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy
por: Krishna, Neel K., et al.
Publicado: (2022)

Incompatible erythrocyte transfusion with lipopolysaccharide induces acute lung injury in a novel rat model
por: Gregory Rivera, Magdielis, et al.
Publicado: (2020)

RLS-0071 Moderated Elevated Myeloperoxidase Level and Activity in an Asymptomatic Subject in Clinical Trial RLS-0071-101
por: Goss, Jessica M., et al.
Publicado: (2023)

MECHANISMS OF IMMUNOLOGIC INJURY OF RAT PERITONEAL MAST CELLS : II. COMPLEMENT REQUIREMENT AND PHOSPHONATE ESTER INHIBITION OF RELEASE OF HISTAMINE BY RABBIT ANTI-RAT GAMMA GLOBULIN
por: Austen, K. Frank, et al.
Publicado: (1966)

MECHANISMS OF IMMUNOLOGIC INJURY OF RAT PERITONEAL MAST CELLS : I. THE EFFECT OF PHOSPHONATE INHIBITORS ON THE HOMOCYTOTROPIC ANTIBODY-MEDIATED HISTAMINE RELEASE AND THE FIRST COMPONENT OF RAT COMPLEMENT
por: Becker, Elmer L., et al.
Publicado: (1966)

Immunology: Are complement lysis and lymphocytotoxicity analogous?
por: Lachmann, P.J.
Publicado: (1983)

Peritoneal Expression of Membrane Complement Regulators Is Decreased in Peritoneal Dialysis Patients with Infected Peritonitis
por: Fukui, Sosuke, et al.
Publicado: (2023)

BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS
por: Ward, Peter A., et al.
Publicado: (1965)

Structural Immunology of Complement Receptors 3 and 4
por: Vorup-Jensen, Thomas, et al.
Publicado: (2018)

Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats
por: WANG, HONGWU, et al.
Publicado: (2014)

The Protease SplB of Staphylococcus aureus Targets Host Complement Components and Inhibits Complement-Mediated Bacterial Opsonophagocytosis
por: Dasari, Prasad, et al.
Publicado: (2022)

IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM
por: Morse, Jane H., et al.
Publicado: (1964)

IMMUNOLOGICAL REACTIONS OF THE COXSACKIE VIRUSES : II. THE COMPLEMENT FIXATION TEST
por: Kraft, Lisbeth M., et al.
Publicado: (1950)

Acute MRSA Sinusitis with Intracranial Extension and Marginal Vancomycin Susceptibility
por: Kumar, Parvathi S., et al.
Publicado: (2013)

Glutathione inhibits antibody and complement-mediated immunologic cell injury via multiple mechanisms
por: Zhang, Zhen, et al.
Publicado: (2017)

Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
por: Agostinis, Chiara, et al.
Publicado: (2021)

Long-term peritoneal dialysate exposure modulates expression of membrane complement regulators in human peritoneal mesothelial cells
por: Kobayashi, Kazuma, et al.
Publicado: (2022)

Icodextrin and spurious hyperglycemia in peritoneal dialysis patients: a hospital-wide attempt to prevent such errors
por: Asakura, Yusuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cafbfask8tu9pisvmli412rbcp